Market Close: The ChiNext Index fell 2.31%, while sectors like oil and pharmaceuticals defied the trend and strengthened.

MetaMuskRat · 2026-04-03T09:52:03+00:00

People's Financial News, April 2nd — Today, the three major indices declined. By the close, the Shanghai Composite Index fell 0.74%, the Shenzhen Component Index dropped 1.6%, and the ChiNext Index declined 2.31%. In terms of sectors, the pharmaceutical sector strengthened, with multiple stocks like JinYao Pharmaceutical hitting the daily limit; the oil sector continued to rise, with China Oil Engineering hitting the limit-up in the afternoon; the electricity sector was somewhat active, with Leshan Electric Power and Sichuan Energy Power hitting the limit-up; additionally, sectors such as pork concept, banking, coal, and gas supply and heating led the gains; sectors like computing power, semiconductors, hotel and catering, and real estate saw the largest declines. About 4,400 stocks in the entire market declined, with total trading volume exceeding 1.8 trillion yuan.

MetaMuskRat

2026-04-03 09:52:03

People’s Finance News, April 2: Today, the three major indexes weakened. As of the close, the Shanghai Composite Index fell 0.74%, the Shenzhen Component Index fell 1.6%, and the ChiNext Index fell 2.31%. On the trading board, the pharmaceutical sector rose, with multiple stocks including Tianjin Pharmaceutical Industry hitting limit-up. The oil sector continued to climb, with China National Petroleum Engineering rising to limit-up in the afternoon. The power sector was partially active, with stocks including Leshan Electric and Chuaneng Power reaching limit-up. In addition, sectors such as pork-related concepts, banks, coal, and supply of gas and heating led the gains. Meanwhile, sectors such as computing power concepts, semiconductors, hotels and catering, and real estate led the declines. Across the whole market, about 4,400 stocks declined, and total trading volume exceeded 1.8 trillion yuan.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.